Effectiveness of mepolizumab in severe asthma in Japan: A real-world study using claims data
Clin Transl Allergy
.
2021 Oct;11(8):e12063.
doi: 10.1002/clt2.12063.
Authors
Hiroyuki Nagase
1
,
Jun Tamaoki
2
,
Takeo Suzuki
3
,
Yasuko Nezu
2
,
Masayuki Katsumata
3
,
Masaki Komatsubara
2
,
George Mu
4
,
Shibing Yang
4
,
Ashley L Cole
4
,
Rafael Alfonso-Cristancho
4
Affiliations
1
Division of Respiratory Medicine and Allergology, Department of Medicine, Teikyo University School of Medicine, Tokyo, Japan.
2
Respiratory Medical Affairs & Development, GSK, Tokyo, Japan.
3
Value Evidence & Outcomes, GSK, Tokyo, Japan.
4
Value Evidence & Outcomes, GSK, Collegeville, Pennsylvania, USA.
PMID:
34708944
PMCID:
PMC8694177
DOI:
10.1002/clt2.12063
No abstract available
Publication types
Letter
Grants and funding
AstraZeneca
213221/GSK
Novartis
Sanofi
Boehringer Ingelheim